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In this Opinion piece we argue that the
tendency of sexually transmitted infections
(STIs) to cause infertility is likely to reflect
an evolutionary adaptation of the patho-
gens. We use an evolutionary perspective
to understand how STI pathogens may
benefit from reducing fertility in the host
and what clues the mechanisms of path-
ogenesis can offer to the evolution of this
ability. While we concentrate on human
infections, we will also briefly discuss the
broader context of STI-induced infertility
in other species.
STIs are a common cause of human
infertility worldwide (Box 1). While several
nonsexually transmitted infections can also
cause infertility (e.g., schistosomiasis, tu-
berculosis, leprosy [1]), these infections are
typically associated with high overall
virulence. In contrast, STIs tend to cause
little mortality and morbidity; thus, the
effect on fertility seems to be more
‘‘targeted’’ and specific. In addition, sev-
eral STI pathogens are also associated
with an increased risk of miscarriage and
infant mortality (Box 1). Reduced fertility
and an increased risk of complications
during and following pregnancy both
contribute to reduced reproductive success
in the host—and may benefit the sexually
transmitted pathogen by destabilizing
partnerships and increasing promiscuity.
The birth of a child has a strong positive
effect on marital stability [2]; conversely,
infertility often results in the break-up of a
couple and a change of partners [3], and a
childless couple may also have increased
rates of extramarital sexual contacts [3].
An STI pathogen that causes infertility or
miscarriage will therefore benefit from
increased rates of partner exchange and
promiscuity, which facilitates its transmis-
sion within the population [4–7]. Preg-
nancy also has a direct negative effect on
sexual activity, which tends to decrease
considerably in the months preceding and
following childbirth [8]; the induction of
infertility, miscarriage, and infant mortal-
ity can therefore facilitate STI transmis-
sion also, by avoiding or reducing
this immediate effect. Finally, STIs are
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Box 1. Major Human STIs That Affect Fertility/Reproduction
The bacteria Chlamydia trachomatis and Neisseria gonorrhoeae are the major
causes of pelvic inflammatory disease (PID), which in untreated women results in
tubal factor infertility in 10%–40% of the cases [31–33] and increases the
probability of ectopic pregnancy by more than 6-fold [31]. These two pathogens
are responsible for more than 200 million new infections per year across the
world [34]; with an estimated probability of PID up to 10%–25% in both infections
[35,36], the global burden of new cases of infertility due to these two pathogens
may exceed 2 million per year. N. gonorrhoeae and, to a lesser extent, C.
trachomatis have also been associated with reduced male fertility (reviewed in
[17]), and both bacteria have been linked to increased risk of perinatal
complications [37]. Treponema pallidum, the bacterial agent of syphilis, causes
about 10 million new infections per year [34], and has a dramatic impact on
pregnancy, with about one-third of untreated cases resulting in perinatal death
(stillbirth or neonatal mortality) and another third in congenital infection
(reviewed in [37]). T. pallidum alone is still responsible for a global burden of
more than 300,000 perinatal deaths per year [38].
In addition to these major bacterial STDs, a number of other bacteria that can
potentially be transmitted by sexual contact (e.g., Gardnerella vaginalis,
Mycoplasma hominis and Mycoplasma genitalium, Ureaplasma urealyticum) have
been associated with bacterial vaginosis, a frequent condition of disturbed
vaginal microflora, which may increase the risk of PID [39,40] and infertility [41] in
women.
The sexually transmitted unicellular eukaryotic parasite Trichomonas vaginalis
infects more than 270 million people per year [34] and increases the probability of
pre-term birth, PID, female tubal, and male infertility [37,42,43]. Finally, some
sexually transmitted viruses have also been implicated in reproductive health:
genital herpes (caused by human herpesvirus types 1 and 2) may cause
miscarriage and/or pregnancy complications [44] and is associated with reduced
fertility in both sexes [45,46]; human papillomaviruses may cause reduced sperm
motility [47] and an increased risk of abortion [48]; human immunodeficiency
virus infection adversely affects sperm quality [49].
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particularly likely to affect the ‘‘hubs’’ or
‘‘core’’ of the sexual network: the individ-
uals of highest promiscuity, who may have
a decisive role in the transmission dynam-
ics [9]. Not only are highly promiscuous
individuals exposed to a higher risk of
acquiring STIs, but STIs may also actively
generate hubs of transmission in a vicious
circle of promiscuity and infertility: in
traditional societies, ‘‘If a woman gets
divorced because of infertility, she may
have to turn to prostitution to survive’’
[10].
While it seems clear that STI pathogens
benefit from inducing infertility in the
infected individuals, this is no direct proof
for the adaptive evolution of this trait. To
ensure sexual transmission, STIs tend to
infect the reproductive tract, and infertility
could potentially arise as a simple by-
product of infection-related damage in the
affected tissues [5,11]. However, a
growing body of evidence indicates the
existence of targeted STI-induced mecha-
nisms that affect fertility, but do not seem to
improve the within-host replication of the
pathogen or increase the contagiousness
of the host (Box 2). Such mechanisms
offer no direct benefit for the pathogen,
and are therefore likely to have evolved
for the indirect benefit afforded by
manipulated host behaviour.
A further argument against the ‘‘acci-
dental’’ nature of STI-induced infertility
is based on the potential resource alloca-
tion trade-off between reproductive and
immune function: infertility may redirect
the energetic costs of reproduction to
maintenance functions including immuni-
ty [12], and a parasite that induces
infertility may therefore be exposed to a
more potent immune response. If STI-
associated infertility were a simple by-
product of no adaptive value to the
pathogen, then the selection pressure
arising from enhanced immunity in ster-
ilized hosts would drive the evolution of
the pathogen towards the loss of the
ability to induce infertility.
We therefore conclude that while STIs
may have indeed been predisposed to
cause infertility, the widespread existence
of targeted pathomechanisms strongly
suggests that this trait has been shaped
by the adaptive evolution of the patho-
gens—which may have implications for
treatments that would specifically target
these mechanisms. If infertility serves the
pathogen only by facilitating transmission,
a treatment or vaccine that specifically
targets a mechanism of infertility is not
going to be opposed by the evolution of
the pathogen within the host—which is
typically the strongest level of selection.
Therefore, the evolution of resistance or
immune escape is much less likely against
such targeted interventions than against
currently used treatments that nearly
always act by inhibiting the life cycle of
the pathogen within the host [13] (e.g.,
emerging drug resistance is a serious
concern in the management of gonorrhoea
[14]). Based on these evolutionary consid-
erations, we propose the development of
novel drugs or vaccines that specifically
target the molecular mechanisms of infer-
tility.
Evolutionary thinking may provide
further clues. While STIs are a major
cause of infertility in women, their contri-
bution to male infertility is relatively
smaller [15–17], and this difference may
also be understood in the context of
pathogen evolution. Infertility destabilizes
a couple, but this effect is not entirely
symmetrical. If the male partner is sterile,
Box 2. Specific Pathomechanisms of Infertility
Here we list known mechanisms of STIs that reduce fertility of the infected
individuals, but provide no apparent benefit for the within-host multiplication or
per-contact transmissibility of the pathogens. In the absence of additional benefit,
the existence of multiple mechanisms (in several cases, within the same species)
indicates that the ability to cause infertility may itself have been selected for
during the evolution of these infectious agents.
N. gonorrhoeae infects the nonciliated cells of the tubal mucosa, but destroys
predominantly the uninfected ciliated cells that have a crucial role in the
transport of fertilized eggs toward the uterus [50]. This effect is mediated by
gonococcal lipopolysaccharides (LPS) that seem to have a targeted effect on the
ciliated cells [51], and by up-regulating the production of tumour necrosis factor
alpha [52]; the latter mechanism is selectively targeted to the uninfected ciliated
cells by a protective anti-apoptotic effect exerted on infected cells by the
pathogen [53]. G. vaginalis also seems to have a targeted mechanism to disable
ciliated cells: filtrates of G. vaginalis cultures can arrest ciliary motility, indicating
the presence of a soluble inhibitory factor [54]. Reduced ciliary activity is likely to
decrease the probability of successful conception in both infections. C.
trachomatis LPS, in turn, has a toxic effect on spermatozoa, which is orders of
magnitude stronger than the effect of LPS from the non-STI bacteria that have
been tested [55].
Chlamydia heat shock protein 60 (hsp60) induces apoptosis in trophoblasts
[56]—cells of the placenta that are vital for normal fetal development [57]: this
damage is likely to contribute to the adverse effect of C. trachomatis on
pregnancy outcome [56]. The apoptotic effect is probably facilitated by the
membrane-associated location of hsp60 in C. trachomatis (in contrast to the
cytoplasmic location typical in other bacteria) [56], which may indicate a
targeted adaptation of the pathogen. N. gonorrhoeae expresses a surface protein
that mimics human chorionic gonadotropin, which has a vital role in pregnancy,
and competitive binding to its receptor may contribute to increased risk of
abortion [58].
The induction of crossreactive antibodies has also been implicated in the
aetiology of infertility. Humoral immunity against chlamydial hsp60 is a predictor
of autoreactive antibodies against human HSP60 and is associated with fallopian
tube damage and increased risk of abortion (reviewed in [59]). In contrast,
immunity against the hsp60 of Escherichia coli is not associated with an antibody
response against the human HSP60 [60]; furthermore, hsp60 is selectively
expressed at high levels also by the persistent form of C. trachomatis, which
down-regulates the expression of most proteins [61]—these two observations are
also consistent with a targeted pathomechanism. In addition, immunity against
chlamydial hsp10 has also been linked to reduced fertility, and may have a
distinct action mechanism by crossreacting with human HSP10, which has an
important role as ‘‘early pregnancy factor’’ during pregnancy [62]. Finally, C.
trachomatis infection increases the incidence of sperm-immobilizing antibodies in
women [63], which may also contribute to infertility. Anti-sperm antibodies are
also found in men with a history of infection, but their effect on fertility is unclear
[64].
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the female may conceive a child from a
single extramarital relationship, and the
couple may be re-stabilized by the birth.
However, if the female is sterile, the couple
will remain childless, and the destabilizing
effect persists. A further asymmetry is
imposed by the direct effects of pregnancy,
which only affect women. Finally, due to
different parental investment of the two
sexes, males have evolved a preference for
higher baseline (uninfected) promiscuity in
humans [18], as well as in most other
species [19], which may allow for greater
gain by manipulating female reproductive
behaviour (in many males realized pro-
miscuity will already be below their
preference). These asymmetries imply that
the benefits of infertility may be greater for
the pathogen when imposed on a female,
compared with a male host. Remarkably,
the higher risk of infertility contrasts with a
lower probability of symptomatic infection
in women compared with men [20]: this
further disconnection between general
virulence (symptoms) and infertility may
also hint at targeted pathomechanisms for
the latter. However, we cannot completely
exclude the simple nonselectionist expla-
nation that ascending infection (associated
with infertility) is more likely in the female
than in the male reproductive system due
to anatomical differences. Furthermore,
STI pathogens present in semen tend to
reduce sperm number and motility
[21,22], which, if sperm acts as a carrier,
may relate reduced fertility to reduced
infectivity and thereby inhibit evolution
towards the former.
Finally, STI-induced infertility is not
limited to human infections, but is a
widespread phenomenon in animal STIs
[4,11]. Note that the effect of infertility on
pathogen transmission is not limited to
monogamous host species, but affects all
species in which promiscuity, or a will-
ingness to mate, decreases with successful
conception. In a broader context, para-
sitic castration is a widespread phenom-
enon in which a parasite (not necessarily
sexually transmitted) reduces host fertility
to increase its own fitness, e.g., by
exploiting the resources diverted from
reproduction [23]. Animal STIs also
provide further examples where the
mechanism of infertility seems unrelated
to the direct growth or transmissibility of
the parasite [11].
While the idea that STIs may have
evolved to induce infertility is not new
[4–6], we have provided here a novel
synthesis of the strong tendency of STIs
to reduce fertility in their hosts, the
evidence that infertility promotes STI
transmission, and the widespread exis-
tence of targeted pathomechanisms that,
taken together, suggest adaptive evolu-
tion of these traits. The public health
implications of infertility and birth
complications associated with STIs are
huge. If not controlled, STI-induced
infertility can reach staggering propor-
tions: extremely high levels of STIs in
some regions of sub-Saharan Africa in
the first half of the 20th century were
associated with rates of infertility ex-
ceeding 40% [24], and similar historical
rates of STIs in the cities of Europe and
North America may have implied a
Box 3. Where Next?
The arguments presented in this paper rely on indirect clues and inferences.
While we believe that, taken together, they put forward a convincing case for the
‘‘adaptive sterilization hypothesis,’’ each line of evidence needs to be subjected to
further tests and systematic analyses for validation. Below we propose some
possibilities to investigate outstanding questions.
1. The association between STIs and infertility should be investigated systemat-
ically. The only study of this kind that we are aware of compiled a massive set of
semiquantitative data on animal STIs [4] and found a somewhat higher
probability of infertility in STIs compared with non-STIs in animals. However, the
study also highlighted the problems of scarce and taxonomically biased data
and of how to select a control set of nonsexually transmitted infections. As more
data emerge, tests should contrast pairs of closely related pathogens, in which
one of the pair is transmitted sexually while the other is transmitted via another
route. However, even careful matching cannot control for the inherent bias that
the majority of STIs infect the genital tract and are therefore predisposed to
inflict damage there.
2. A more promising approach involves investigating the patterns of infertility
among STIs that infect various host species. Based on the reproductive
behaviour of the hosts (e.g., monogamy versus polygamy, continuous
versus seasonal mating, parental care) and other life history traits of both
the host and the pathogen (e.g., lifespan, duration of infection), the effect
of infertility on promiscuity is likely to vary considerably, and may be
predictable to some extent. A correlation between the predicted strength of
this effect and the probability of infertility in different STIs would support
the adaptive hypothesis. Differential effects may also be predicted for the
two genders of the same species (as we proposed for human STIs), and this
could also be correlated with the probability of STI-induced infertility in the
two sexes.
3. The targeted pathomechanisms of infertility could be further investigated using
comparative phylogenetic analyses of the pathogen species. The adaptive
hypothesis postulates that specific pathomechanisms evolved as the pathogens
adapted to sexual transmission: these traits should therefore appear coincident
with the switch to sexual transmission in the phylogenetic trees including an STI
pathogen and its closely related non-STI sister taxa. E.g., the sexually transmitted
lineages (serovars) of C. trachomatis could be compared with the non-STI
serovars associated with trachoma, or with C. pneumoniae [65]. Currently
available data only allowed for comparisons with distantly related species (Box
2), but future research is likely to open possibilities for more informative
comparisons.
4. Finally, more clinical and laboratory research is needed to expand our general
knowledge on the impact of human (and nonhuman) STIs on fertility. Even
with the most studied STIs, quantitative estimates of infertility are rare. We
were only able to draw quantitative estimates for N. gonorrhoeae and C.
trachomatis, and even in these, only for women, and we had to resort to
extrapolating the probability of infertility following infection from the
probability of PID in these STIs and the general probability of infertility
following PID. However, it is unknown whether PID cases of different aetiology
differ in the probability of inducing infertility. Quantitative data would also be
needed for the impact of other STIs, including the (quantitative) effect of the
infections on male fertility.
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similar impact up to the beginning of
the 20th century [25,26]. Even today,
STIs are an important cause in the
estimated 9% global prevalence of
infertility [27], and a cause of a terrible
emotional burden [28] and loss of
(unborn) lives. Evolutionary perspec-
tives [6,7,29,30] may help us under-
stand these infections and may offer
clues in the fight against them. We hope
that our brief exposition of the ‘‘adap-
tive sterilization hypothesis’’ will
prime further discussion and motivate
new research to better define the limits
of the validity of the hypothesis
(Box 3).
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